Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: Relevance to drug resistance
about
The L76V Drug Resistance Mutation Decreases the Dimer Stability and Rate of Autoprocessing of HIV-1 Protease by Reducing Internal Hydrophobic ContactsCritical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitorsTerminal Interface Conformations Modulate Dimer Stability Prior to Amino Terminal Autoprocessing of HIV-1 ProteaseExtreme Multidrug Resistant HIV-1 Protease with 20 Mutations Is Resistant to Novel Protease Inhibitors with P1′-Pyrrolidinone or P2-Tris-tetrahydrofuranHIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural RearrangementsStructures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open FlapsStructural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap DynamicsTransition states of native and drug-resistant HIV-1 protease are the same.Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors.Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20Mechanism of dissociative inhibition of HIV protease and its autoprocessing from a precursor.Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature EnzymeEnhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap-Core Interface of HIV-1 Protease
P2860
Q27667353-048ACC54-76CA-49E7-85D0-9247D3FA6F86Q27676688-F35893D7-855D-4E94-8299-6992EAD6B136Q27676717-31CB2C0D-D26D-4C94-9BEA-6A7A3FBFE337Q27677405-AAAF30C5-F26A-4BB9-B27C-CDD24640A152Q27677952-A4FCA293-BC94-4CD8-887B-D8A0E7203CBEQ27683434-FB3FDF70-B5BA-4C92-AE76-5C0D970F0DDBQ28555090-F586330E-1E5C-4CC0-A00F-47835844D31CQ34031459-EFACAA84-8DF2-4E77-B83E-F58874D4F5B2Q35022049-904BEEFD-3395-413C-B5AD-9CBFA306E5D7Q35909838-4CD0ADB1-6F03-40B0-8FFD-B3B95B079072Q36162047-22B69E83-FB31-4DAD-8B6B-028D0DB4A4A5Q37237447-39B373A6-369B-4661-8D3F-FF0F59EA2701Q37463212-1B63638B-C7EA-450E-BE12-AF3BA7565818Q41490002-6917DDE1-28DA-4796-B73B-A2F210CADB03Q57063482-1D777DC9-C3A0-4BE8-A366-9858D9F03369
P2860
Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: Relevance to drug resistance
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@ast
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@en
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@nl
type
label
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@ast
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@en
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@nl
prefLabel
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@ast
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@en
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@nl
P2093
P2860
P356
P1433
P1476
Autocatalytic maturation, phys ...... : Relevance to drug resistance
@en
P2093
Irene T Weber
Jane M Sayer
John M Louis
P2860
P304
P356
10.1002/PRO.486
P577
2010-11-01T00:00:00Z